Alumni College: Play Ball!

An upcoming Alumni College seminar will explore the financial side of America's favorite sport, followed by a field trip to Fenway Park for an...

An upcoming Alumni College seminar will explore the financial side of America's favorite sport, followed by a field trip to Fenway Park for an afternoon game. "The Business of Baseball," to be held on Saturday, May 29, will start with panel discussions at the Harvard Club of Boston at 374 Commonwealth Avenue. The morning agenda includes:

Peter Carfagna '75, J.D. '79, general counsel for International Management Group, a Cleveland, Ohio-based, sports marketing and management agency, who will discuss the agent's perspective.

Tom Werner '71, an owner and chairman of the Boston Red Sox, who will address the owner's point of view.

Janet Marie Smith, an architect and team vice president of planning and development, who will talk about Fenway's past and future architectural design.

Later, attendees will head to Fenway to see the Sox host the Seattle Mariners.

Pre-registration is required. To sign up on-line, visit www.haa.harvard.edu and click on "Alumni College." For more information, e-mail haa_alumnicollege@harvard.edu or call 617-495-1920.

     

Most popular

Five Questions with Michèle Duguay

Harvard scholar of music theory on how streaming services have changed the experience of music.

Harvard art historian Jennifer Roberts teaches the value of immersive attention

Teaching students the value of deceleration and immersive attention

Explore More From Current Issue

A diverse group of adults and children holding hands, standing on varying levels against a light blue background.

Why America’s Strategy For Reducing Racial Inequality Failed

Harvard professor Christina Cross debunks the myth of the two-parent Black family.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.